BioStocksCan @StocksBio

Canadian Biotech investor focused on: - Solid Science - Great Management - High Insider % Ownership - Low Float - Extreme Growth Opportunities Canada Joined December 2020

Tweets

4
Followers

5
Following

21
Likes

2

BioStocksCan @StocksBio

6 years ago

@Autophagy13 A bit delayed.. Q1 2021 clinical data. Should be interesting. LTB4 implicated in Asthma and other lung conditions. Good chance nomacopan a viable covid pneumonia therapy.

0 0 0 0 0

View Details

$AKTX #BP #TMA #Covid19 #AKC #AMD #Asthma #PNH #Investing #biotech <80M market cap in a market complement space with $1B-39B acquisitions. Multi-Billion opportunity. Two P-III studies more eye and covid19 pneumonia data on the way. tinyurl.com/yybc8v5w

0 0 0 0 0

View Details

BioStocksCan @StocksBio

6 years ago

#2021biobuyout $AKTX $13.50 per share buyout in 2021 current share price $1.80-1.90 #PNH #AKC #COVID19 #TMA #BP #biotech

0 0 1 0 0

View Details

BioStocksCan @StocksBio

6 years ago

@JamesEKrause Expecting $AKTX's Nomacopan (C5 + LTB4 Inhibitor) Covid19 therapeutic clinical results in the coming days to draw attention to the significance of complement. #PNH #TMA #BP #RA #AKC #Uveitis #AMD #ARDS #COVID19

0 0 1 0 0

View Details

Elovar @Elovar5019

34 Followers 1K Following

Speasmi @Speasmidq1hs3l

33 Followers 4K Following

MonaCrichton @nvQuG40NrRcId

72 Followers 7K Following

Harriet @kadokiwaka590

81 Followers 7K Following

Father of 2 beautiful girls Husband to a perfect wife Try to get better everyday with a dream to change the world for the better.

Palmer Karr @palmerkarr

253 Followers 849 Following Father of 2 beautiful girls Husband to a perfect wife Try to get better everyday with a dream to change the world for the better.

A forum that uses the markets as the ultimate teacher and provides unique perspective on #BITCOIN, #Bonds, #Stocks, #Commodities, global trends, and #Cycles.

Eric De Groot @supreed

3K Followers 23 Following A forum that uses the markets as the ultimate teacher and provides unique perspective on #BITCOIN, #Bonds, #Stocks, #Commodities, global trends, and #Cycles.

I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

Biotechnology Innovat... @IAmBiotech

105K Followers 6K Following I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54

Adam Feuerstein ✡�... @adamfeuerstein

132K Followers 758 Following Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54

News affecting the biotech industry and associated stocks. Includes #biotech trends, market analysis as well as mergers and acquisition news. cc: @TheStreet

TheStreet Biotech @TSTbiotech

6K Followers 49 Following News affecting the biotech industry and associated stocks. Includes #biotech trends, market analysis as well as mergers and acquisition news. cc: @TheStreet

Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - https://t.co/K2nAJlm94m.

FDA Drugs and Biologi... @FDADrugs

351K Followers 44 Following Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or [email protected]. Privacy Policy - https://t.co/K2nAJlm94m.

U.S. FDA @FDA

592K Followers 81 Following Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0

Investor/trader focused primarily in the biopharma sector.
Tweets are not investment advice and are not recommendations of any kind.

Bio Stocks™ @BioStocks

72K Followers 93 Following Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.

BioShockers is focused on biotech/pharma stocks! We usually sell for a 20%+ gain in the anticipation Run-Up, and occasonally hold thru the catalyst.

BioShockers @BioShockers

552 Followers 63 Following BioShockers is focused on biotech/pharma stocks! We usually sell for a 20%+ gain in the anticipation Run-Up, and occasonally hold thru the catalyst.

Amel @AmelFl

497 Followers 257 Following Part-Time Trader - Houston Rockets Enthusiast - @amelfl.bsky.social

http://t.co/qe8HMo49K9 is a blog that provides daily biotech market updates (doses), analysis, and education to the biotech investor.

BiotechInvestor.com @Biotechinvesto9

1K Followers 6 Following http://t.co/qe8HMo49K9 is a blog that provides daily biotech market updates (doses), analysis, and education to the biotech investor.

Internal Medicine, Clinical Pharmacology/Toxicology and drug safety research @Sunnybrook and @UofTMedicine. Inexplicably fortunate husband.

David Juurlink @DavidJuurlink

66K Followers 788 Following Internal Medicine, Clinical Pharmacology/Toxicology and drug safety research @Sunnybrook and @UofTMedicine. Inexplicably fortunate husband.

Right to the point news on stocks, cryptocurrencies and the markets. Access all content with free trial at https://t.co/5eRU7AlZGs.

The Fly @theflynews

29K Followers 215 Following Right to the point news on stocks, cryptocurrencies and the markets. Access all content with free trial at https://t.co/5eRU7AlZGs.

BIOTECH @_B_I_O_T_E_C_H_

10K Followers 155 Following no advice / art / sarcasm / free speech

Investor since late 2018; Here to Learn and Invest; Tweets are for information only and not investment advice. Do your own DD

StockTradeKing @Stocktradeking

434 Followers 2K Following Investor since late 2018; Here to Learn and Invest; Tweets are for information only and not investment advice. Do your own DD

Endpoints News founder, stage 4 Merkel cell carcinoma and author of the forthcoming book, Metastatic: Navigating America’s screwed up cancer care system.

John D Carroll @JohnCendpts

71K Followers 109 Following Endpoints News founder, stage 4 Merkel cell carcinoma and author of the forthcoming book, Metastatic: Navigating America’s screwed up cancer care system.

Journalist @ApexOnco. The Wolverine Of Biotech / Mr ASH. Interested in: oncology. Not interested in: what stock you bought today. My internal plan is as follows

Jacob Plieth @JacobPlieth

33K Followers 283 Following Journalist @ApexOnco. The Wolverine Of Biotech / Mr ASH. Interested in: oncology. Not interested in: what stock you bought today. My internal plan is as follows

Brad Loncar @bradloncar

83K Followers 369 Following #Biotech, Founder of @BiotechTV, KC native, @univmiami hurricane.🧬🙌

Endpoints News @endpts

33K Followers 80 Following The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSx

phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids

Biotech Jim @JamesEKrause

13K Followers 607 Following phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids

Trader & Investor 41 years experience, NYT Bestseller Millionaire Dropout, Author, Financial Spread Trading, Derivatives, Tobacco, Gold, Energy & Short seller

Vince Stanzione @Vince_Stanzione

9K Followers 44 Following Trader & Investor 41 years experience, NYT Bestseller Millionaire Dropout, Author, Financial Spread Trading, Derivatives, Tobacco, Gold, Energy & Short seller

#Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice

Andy Biotech @AndyBiotech

75K Followers 718 Following #Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice